638 results on '"Kobinger, Gary P."'
Search Results
52. Impact of Systemic or Mucosal Immunity to Adenovirus on Ad-Based Ebola Virus Vaccine Efficacy in Guinea Pigs
53. Replication, Pathogenicity, Shedding, and Transmission of Zaire ebolavirus in Pigs
54. A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity
55. Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia
56. Assessment of the Efficacy of Commercially Available and Candidate Vaccines against a Pandemic H1N1 2009 Virus
57. Stimulation of Ebola Virus Production from Persistent Infection through Activation of the Ras/MAPK Pathway
58. Mucosal Delivery of Adenovirus-Based Vaccine Protects against Ebola Virus Infection in Mice
59. Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in Macaques
60. Safety and Immunogenicity of an Anti–Zika Virus DNA Vaccine
61. Safety and Tolerability of the Adeno-Associated Virus Vector, AAV6.2FF, Expressing a Monoclonal Antibody in Murine and Ovine Animal Models
62. Crimean-Congo Hemorrhagic Fever Virus in Asia, Africa and Europe
63. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA
64. Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in Macaques.
65. SARS-CoV-2 spillover transmission due to recombination event
66. Ebola virus is unlikely to become endemic in West Africa
67. Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals
68. Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia.
69. Experimental countermeasures against Ebola virus: current progress and an ethical conundrum
70. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae
71. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae
72. The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19
73. Altered microRNA Transcriptome in Cultured Human Liver Cells upon Infection with Ebola Virus
74. Characterization of Ebola Virus Risk to Bedside Providers in an Intensive Care Environment
75. Construction of a ganciclovir-sensitive lentiviral vector to assess the influence of angiopoietin-3 and soluble Tie2 on glioma growth
76. Antibody therapy for Ebola: Is the tide turning around?
77. Modeling host-feeding preference and molecular systematics of mosquitoes in different ecological niches in Canada
78. Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques
79. Immunogenicity of novel consensus-based DNA vaccines against avian influenza
80. Hypothesis driven development of new adjuvants Short peptides as immunomodulators
81. Physiological modulation of CFTR activity by AMP-activated protein kinase in polarized T84 cells
82. Evaluation of mismatched immunity against influenza viruses
83. Ebola and Marburg
84. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity
85. Oral Vaccination With Recombinant Vesicular Stomatitis Virus Expressing Sin Nombre Virus Glycoprotein Prevents Sin Nombre Virus Transmission in Deer Mice
86. The Cellular Impact of the ZIKA Virus on Male Reproductive Tract Immunology and Physiology
87. Dual RNA-Seq characterization of host and pathogen gene expression in liver cells infected with Crimean-Congo Hemorrhagic Fever Virus
88. Safety and immunogenicity of vesicular stomatitis virus-based vaccines for Ebola virus disease
89. Mosquito Species Composition and Abundance in Quebec, Eastern Canada
90. Correction: DNA barcodes corroborating identification of mosquito species and multiplex real-time PCR differentiating Culex pipiens complex and Culex torrentium in Iran
91. Fluorescent Crimean-Congo hemorrhagic fever virus illuminates tissue tropism patterns and identifies early mononuclear phagocytic cell targets in Ifnar-/- mice
92. Recent advances in Ebolavirus vaccine development
93. Syrian Hamsters as a Small Animal Model for Emerging Infectious Diseases: Advances in Immunologic Methods
94. Human fetal trachea-scid mouse xenografts: efficacy of vesicular stomatitis virus-G pseudotyped lentiviral-mediated gene transfer
95. Create one new species in the genus Ebolavirus (Mononegavirales: Filoviridae)
96. Two (2) new genera each including one (1) novel species in the family Filoviridae (Mononegavirales)
97. Consequences of Pathogen Lists: Why Some Diseases May Continue to Plague Us
98. Challenges and perspectives on the use of mobile laboratories during outbreaks and their use for vaccine evaluation
99. 2017 Outbreak of Ebola Virus Disease in Northern Democratic Republic of Congo
100. Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.